Efficacy and tolerability of pegylated interferon-alpha2a plus ribavirin versus pegylated interferon-alpha2b plus ribavirin in treatment-naive chronic hepatitis C patients.

Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ

History

Optimizing Patient Eng

Principal Investigator

PhSc 7104, Pharmaceuti

Principal Investigator

Efficacy and tolerabil

See All (20) pages

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Efficacy and tolerability of pegylated interferon-alpha2a plus ribavirin versus pegylated interferon-alpha2b plus ribavirin in treatment-naive chronic hepatitis C patients.

Lee S, Kim IH, Kim SH, Kim SW, Lee SO, Lee ST, Kim DG, Lee CS, Choi CS, Cho EY, Kim HC. Efficacy and tolerability of pegylated interferon-alpha2a plus ribavirin versus pegylated interferon-alpha2b plus ribavirin in treatment-naive chronic hepatitis C patients. Intervirology. 2010; 53(3):146-53.

View in: PubMed

subject areas

Adult
Aged
Antiviral Agents
Female
Hepatitis C, Chronic
Humans
Interferon-alpha
Liver Function Tests
Male
Middle Aged
Polyethylene Glycols
Recombinant Proteins
Ribavirin
RNA, Viral
Treatment Outcome
Viral Load

authors with profiles

Ha-Neui Kim